1. Home
  2. AIBZ vs AKBA Comparison

AIBZ vs AKBA Comparison

Compare AIBZ & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bitzero Holdings Inc. Common Shares

AIBZ

Bitzero Holdings Inc. Common Shares

BUY

Current Price

$2.81

Market Cap

255.0M

Sector

N/A

ML Signal

BUY

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$0.57

Market Cap

248.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIBZ
AKBA
Founded
N/A
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.0M
248.3M
IPO Year
2026
2014

Fundamental Metrics

Financial Performance
Metric
AIBZ
AKBA
Price
$2.81
$0.57
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $3.92
AVG Volume (30 Days)
771.9K
★ 7.5M
Earning Date
11-18-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 93.94
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$0.54
52 Week High
$9.91
$3.19

Technical Indicators

Market Signals
Indicator
AIBZ
AKBA
Relative Strength Index (RSI) 36.88 19.49
Support Level $2.22 N/A
Resistance Level $7.21 $0.98
Average True Range (ATR) 0.45 0.05
MACD 0.03 -0.02
Stochastic Oscillator 31.72 6.81

Price Performance

Historical Comparison
AIBZ
AKBA

About AIBZ Bitzero Holdings Inc. Common Shares

Bitzero Holdings Inc is a provider of IT energy infrastructure and high-efficiency power for data centers. It focuses on data center development, Bitcoin mining, and obtaining strategic data center hosting partnerships. The company has four data center locations in the North American and Scandinavian regions, powered by clean, low-carbon energy sources. The company is driven by experience in infrastructure and a passion for positive change to become the international leader in Blockchain mining and HPC hosting in a sustainable fashion that emphasizes the long-term value proposition for all stakeholders.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: